Profile data is unavailable for this security.
About the company
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
- Revenue in USD (TTM)347.03m
- Net income in USD-25.38m
- Incorporated2001
- Employees766.00
- LocationInogen Inc859 WARD DRIVEGOLETA 93111United StatesUSA
- Phone+1 (805) 562-0500
- Fax+1 (302) 636-5454
- Websitehttps://www.inogen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | 218.88m | -50.11m | 133.17m | 477.00 | -- | 1.49 | -- | 0.6084 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
| Cibus Inc | 3.79m | -118.90m | 135.80m | 157.00 | -- | 2.09 | -- | 35.79 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Fonar Corp | 105.43m | 6.99m | 137.54m | 535.00 | 17.96 | 0.7009 | 9.80 | 1.30 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LifeMD Inc | 252.34m | -7.71m | 146.81m | 304.00 | -- | 108.11 | 29.73 | 0.5818 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| LENSAR Inc | 59.14m | -51.52m | 148.47m | 140.00 | -- | -- | -- | 2.51 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 148.97m | 288.00 | 10.97 | 1.01 | 7.37 | 1.81 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 154.76m | 502.00 | 29.09 | 2.79 | 8.17 | 1.10 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Inogen Inc | 347.03m | -25.38m | 156.10m | 766.00 | -- | 0.7917 | -- | 0.4498 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 158.42m | 72.00 | -- | -- | -- | 36.01 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
| Citrine Global Corp | 0.00 | -1.74m | 160.44m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 163.24m | 220.00 | -- | 25.74 | -- | 3.41 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 164.72m | 165.00 | -- | 0.993 | -- | 13.39 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 167.50m | 633.00 | 18.08 | 1.45 | 10.31 | 0.8591 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Edap Tms SA (ADR) | 75.88m | -23.35m | 171.73m | 310.00 | -- | 6.19 | -- | 2.26 | -0.6235 | -0.6235 | 2.02 | 0.7418 | 0.9081 | 2.08 | 3.62 | 244,774.70 | -27.94 | -11.18 | -49.24 | -15.86 | 43.24 | 42.19 | -30.77 | -16.63 | 0.9729 | -- | 0.2062 | -- | 6.11 | 7.38 | 10.20 | -- | 55.92 | -- |
| CVRx Inc | 55.97m | -52.02m | 175.35m | 206.00 | -- | 3.65 | -- | 3.13 | -2.02 | -2.02 | 2.18 | 1.83 | 0.4684 | 0.7458 | 6.49 | 271,694.20 | -43.53 | -37.08 | -47.98 | -40.02 | 84.49 | 81.33 | -92.95 | -151.18 | 8.60 | -8.49 | 0.5072 | -- | 30.53 | 52.31 | -45.55 | -- | 66.61 | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 180.84m | 163.00 | -- | 4.08 | -- | 5.92 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
Data as of Feb 10 2026. Currency figures normalised to Inogen Inc's reporting currency: US Dollar USD
33.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 1.49m | 5.50% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.26m | 4.64% |
| Acadian Asset Management LLCas of 30 Sep 2025 | 1.07m | 3.93% |
| Camber Capital Management LPas of 30 Jun 2025 | 975.00k | 3.59% |
| Armistice Capital LLCas of 30 Sep 2025 | 864.00k | 3.18% |
| Columbia Management Investment Advisers LLCas of 30 Sep 2025 | 852.73k | 3.14% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 792.63k | 2.92% |
| Geode Capital Management LLCas of 30 Sep 2025 | 609.29k | 2.24% |
| DAFNA Capital Management LLCas of 30 Sep 2025 | 605.63k | 2.23% |
| Royce & Associates LPas of 30 Sep 2025 | 600.97k | 2.21% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
